Category: Smith & Nephew
Here's a look at some of the top Wall Street stories for medical device companies this week: Will Stryker bid on Smith & Nephew this week?; Medtronic expects to free up to $4B after IRS beef is settled; Second Sight CEO Greenberg: Next-gen 'bionic eye' could treat nearly all forms of blindness; HCA hospitals halt use of uterine fibroid surgical tool
Smith & Nephew CEO Olivier Bohuon reportedly tells employees that he's not in the running for the top job at French drug maker Sanofi.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Will Stryker bid on Smith & Nephew this week?: J&J demands $7.2 billion from Boston Scientific as trial begins; Will Orange County's medtech scene lose its juice without Allergan?; BD-CareFusion deal passes US anti-trust waiting period; Sources: Stryker weighs bid for Smith & Nephew
, Becton Dickinson & Co.
, Boston Scientific
, CareFusion Corp.
, Guidant Corp.
, Johnson & Johnson
, Smith & Nephew
, Stryker Corp.
, Valeant Pharmaceuticals
, Allergan Inc.
Anonymous sources confirm speculation that Stryker is weighing a bid for British orthopedics rival Smith & Nephew.
Speculation mounts again about a possible Stryker offer for Smith & Nephew now that a 6-month no-bid period has ended.
UPDATED Nov. 24 with analysis from Morgan Stanley.
Smith & Nephew deals its wound management plant in Gilberdyke, England, to DelStar Medical for an undisclosed amount.
Smith & Nephew is reportedly shuttering a wound management unit in St. Petersburg, Fla., meaning layoffs for the 108 workers there.